NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Price: 1.54 for April 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 05, 2024 | 1.54 | 1.54 | 1.54 | 1.54 | 0.000 |
| Apr 04, 2024 | 1.56 | 1.57 | 1.54 | 1.54 | 2.391M |
| Apr 03, 2024 | 1.56 | 1.57 | 1.55 | 1.56 | 771099.0 |
| Apr 02, 2024 | 1.56 | 1.57 | 1.55 | 1.56 | 869724.0 |
| Apr 01, 2024 | 1.56 | 1.58 | 1.55 | 1.56 | 1.331M |
| Mar 28, 2024 | 1.59 | 1.60 | 1.555 | 1.59 | 357153.0 |
| Mar 27, 2024 | 1.55 | 1.63 | 1.53 | 1.62 | 3.297M |
| Mar 26, 2024 | 1.55 | 1.57 | 1.55 | 1.55 | 771033.0 |
| Mar 25, 2024 | 1.56 | 1.60 | 1.55 | 1.55 | 1.363M |
| Mar 22, 2024 | 1.56 | 1.58 | 1.54 | 1.55 | 1.558M |
| Mar 21, 2024 | 1.55 | 1.57 | 1.54 | 1.56 | 1.026M |
| Mar 20, 2024 | 1.55 | 1.56 | 1.54 | 1.55 | 1.092M |
| Mar 19, 2024 | 1.55 | 1.57 | 1.545 | 1.56 | 1.322M |
| Mar 18, 2024 | 1.55 | 1.569 | 1.55 | 1.56 | 1.055M |
| Mar 15, 2024 | 1.53 | 1.58 | 1.53 | 1.57 | 1.176M |
| Mar 14, 2024 | 1.53 | 1.545 | 1.53 | 1.53 | 329341.0 |
| Mar 13, 2024 | 1.53 | 1.56 | 1.53 | 1.53 | 363666.0 |
| Mar 12, 2024 | 1.53 | 1.585 | 1.53 | 1.54 | 913193.0 |
| Mar 11, 2024 | 1.53 | 1.55 | 1.52 | 1.54 | 2.353M |
| Mar 08, 2024 | 1.53 | 1.545 | 1.52 | 1.53 | 328294.0 |
| Mar 07, 2024 | 1.53 | 1.54 | 1.52 | 1.53 | 448353.0 |
| Mar 06, 2024 | 1.53 | 1.540 | 1.52 | 1.52 | 332320.0 |
| Mar 05, 2024 | 1.52 | 1.55 | 1.52 | 1.53 | 500879.0 |
| Mar 04, 2024 | 1.52 | 1.55 | 1.52 | 1.52 | 355687.0 |
| Mar 01, 2024 | 1.52 | 1.54 | 1.52 | 1.52 | 739438.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6003
Minimum
Nov 17 2023
31.93
Maximum
Mar 17 2021
13.74
Average
15.21
Median
Feb 18 2022
Price Benchmarks
| Catalent Inc | 55.37 |
| AIM ImmunoTech Inc | 0.403 |
| Perspective Therapeutics Inc | 1.60 |
| Protalix BioTherapeutics Inc | 1.14 |
| Armata Pharmaceuticals Inc | 2.59 |
Price Related Metrics
| PS Ratio | 28.76 |
| Price to Book Value | 0.8647 |
| Earnings Yield | -112.3% |
| Market Cap | 128.53M |